Accretion Nutraveda IPO

Accretion Nutraveda is a BSE SME IPO listed on the BSE SME platform, priced at ₹122–₹129 per share. The stock debuted at ₹191, delivering a listing gain of 48.1%. The IPO had a lot size of ₹1000 shares and a minimum investment of ₹2,58,000.

Accretion Nutraveda Limited IPO

BSE SME Listed
₹2,58,000 (2000 Shares)
Minimum Investment
Check Allotment
IPO Dates
Jan 28, 2026 – Jan 30, 2026
Price band
₹122-129 per equity share
Minimum Investment
₹2,58,000
Issue size
₹24.77 Cr
Lot size
1000
Allotment Date
Feb 2, 2026
Listing
Feb 4, 2026
Listing At
BSE SME

IPO timeline

  1. Jan 28, 2026

    Open Date

    Completed

  2. Jan 30, 2026

    Close Date

    Completed

  3. Feb 2, 2026

    Allotment Date

    Completed

  4. Feb 4, 2026

    Listing Date

    Completed

Accretion Nutraveda IPO Subscription Details

View Subscription Details
QIB 1.01x
Individual 2.19x
NIIs 2.42x
bHNI 2.47x
sHNI 2.33x
Individual 2.19x
Total 1.91x

Accretion Nutraveda IPO subscription status shows demand across QIB, NII, and retail categories, helping investors understand participation levels.

Last updated:

Accretion Nutraveda IPO Essentials

Accretion Nutraveda IPO Details

Accretion Nutraveda IPO is priced at ₹122-129 per share with a total issue size of 24.77 crore. The IPO has a lot size of 1000 shares and is listed on BSE SME.

Issue price
₹122-129 per equity share
Lot size
1000 shares
Face value
₹10 Per Equity Share
Issue size
19,20,000 shares(aggregating up to ₹24.77 Cr)
Total issue size
19,20,000 shares
(aggregating up to ₹24.77 crore)
Fresh issue
19,20,000 shares
(aggregating up to ₹24.77 crore)
Listing at
BSE SME
List price
191.0
Listing date
Registrar
Kfin Technologies Ltd.
Lead manager
Sobhagya Capital Options Pvt.Ltd.

Market Lot Size

Investors can bid for a minimum of 2000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors and HNI in terms of shares and amount.

Application Lots Shares Amount
Individual (min) 2 2000 ₹2,58,000
Individual(max) 2 2000 ₹2,58,000
sHNI(min) 3 3000 ₹3,87,000
sHNI(max) 7 7000 ₹9,03,000
sHNI(min) 8 8000 ₹10,32,000

Accretion Nutraveda IPO Documents

Accretion Nutraveda IPO Reservation

Accretion Nutraveda IPO reservation details show category-wise allocation of shares. Out of the total 1920000 shares, approximately 18.96% are reserved for QIB, 14.38% for NII, 33.33% for retail investors, 5% for market maker, and 28.33% for anchor investors.

Investor Category Shares Offered Maximum Allottees
Anchor Investor Shares Offered 544000 (28.33%)
Market Maker Shares Offered 96000 (5%)
QIB Shares Offered 364000 (18.96%)
NII (HNI) Shares Offered 276000 (14.38%)
bHNI > ₹10L 184000 (9.39%) 61
sHNI < ₹10L 92000 (4.85%) 31
Individual Shares Offered 640000 (33.33%) 320
Total Shares Offered 1920000 (100%)

Accretion Nutraveda IPO Analytics

Accretion Nutraveda IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.

Accretion Nutraveda IPO Subscription Status

Accretion Nutraveda IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.

The IPO is currently subscribed 1.91x, indicating moderate demand across investor categories.

As on QIB
NII
bHNI
sHNI
Individual Total
Shares Offered / Reserved 3,64,000
2,76,000
1,84,000
92,000
6,40,000 12,80,000
Day 1 28-01-26 05:00 PM
0.00 x
0.45x
0.57x
0.23x
0.21 x 0.20 x
Day 2 29-01-26 05:00 PM
0.99 x
0.99x
1.00x
0.98x
0.43 x 0.71 x
Day 3 30-01-26 05:00 PM
1.01 x
2.42x
2.47x
2.33x
2.19 x 1.91 x
Day 4 02-02-26 05:00 PM
1.01 x
2.42x
2.47x
2.33x
2.19 x 1.91 x
Total No. of Applications
bHNI sHNI Individual
811 (Approx) 0.74x 2x 2.19x

Accretion Nutraveda Valuations

Earnings

EPS Pre IPO
₹4.91/-
EPS Post IPO
₹6.44/-
P/E Pre IPO
26.27
P/E Post IPO
20.02

Returns

ROE
81.22%
ROCE
36.98%
RoNW
48.85%
PAT Margin
16.33%

Fundamentals

Debt / Equity
0.72
Price / Book
8.76
Market Cap
93.40 Cr.

Data sourced from DRHP / RHP • For educational purposes only

Accretion Nutraveda Financials( In Crs.)

31-Mar-25 31-Mar-24 31-Mar-23
Assets 10.86 4.64 4.06
Revenue 16.06 5.20 3.07
Profit After Tax 2.61 0.82 0.28
Net Worth 5.35 1.08 0.26
Reserves & Surplus 4.86 0.72 -0.10
Total Borrowing 3.86 2.17 1.97

Accretion Nutraveda Company & Offer Insights

About Accretion Nutraveda

Incorporated in the year 2021, Accretion Nutraveda is engaged in the manfacturing of Ayurvedic and nutraceutical products in different dosage forms, which include tablets, capsules, oral liquids, powders, oils, and external preparations such as balms, creams, and gels.
The company is a Contract Development and Manufacturing Organization (CDMO) that caters to both local and international markets, including Sri Lanka, Singapore, and USA. It provides products that incorporate the wisdom of Ayurvedic science, along with the latest nutraceutical technology, to alleviate conditions such as liver care, women’s health, boneness and joint care, brain support, and respiratory health.

Business verticals:
Domestic Sales & Merchant Exports (Loan Licence Basis) - contributing 96.62% to total revenues in FY 2024-25.
Direct Exports– Contributing 38%, with a constant rise in It has a manufacturing plant in Gujarat which occupies around 10,763 sq. ft. and is well-equipped with latest infrastructure like 13 air handling units, processing areas, and quality control equipment. The plant is GMP, WHO-GMP, FSSC 22000, ISO 9001:2015, ISO 45001:2018, and Halal certified along with FSSAI license.

Accretion Nutraveda Promoter(s)

Mr. Mayur Popatlal Sojitra, Mr. Ankurkumar Shantilal Patel, Mr. Paraskumar Vinubhai Parmar, Mr. Hardik Mukundbhai Prajapati, Mr. Harshad Nanubhai Rathod & Mr. Vivek Ashok Kumar Patel are the company's promoters of Accretion Nutraveda.

Accretion Nutraveda IPO Issue Objectives

Purchase of Machineries for Automation in existing Manufacturing unit
Purchase of Machineries for New Manufacturing Setup
Funding working capital requirements of our company
General corporate purposes

Contact Information

Contact Details

Accretion Nutraveda

+91 9904366177

compliance@accretionnutraveda.com

http://www.accretionnutraveda.com/

27 Xcelon Industrial Park-1 Vasna-Chacharwadi, Ta-Sanand, Ahmedabad, Gujarat, 382213

Registrar Contact Details

Kfin Technologies Limited

04067162222, 04079611000

citichemindia.ipo@kfintech.com

https://ipostatus.kfintech.com/

Frequently Asked Questions

Click any question to reveal the answer

Accretion Nutraveda IPO is a book-built IPO worth ₹24.77 crore. The price band is ₹122–₹129 per share. The IPO opens on Jan 28, 2026 and closes on Jan 30, 2026. It will be listed on BSE SME Platform. Kfin Technologies Ltd. is the registrar.

The price band of Accretion Nutraveda IPO is ₹122 to ₹129 per share.

The lot size of Accretion Nutraveda IPO is 1000 shares.

The minimum investment for Accretion Nutraveda IPO is approximately ₹2,58,000 based on the upper price band .

Accretion Nutraveda IPO opens on Jan 28, 2026 and closes on Jan 30, 2026.

The allotment date of Accretion Nutraveda IPO is Feb 2, 2026.

Accretion Nutraveda IPO is expected to be listed on Feb 4, 2026, on BSE SME Platform.

Accretion Nutraveda IPO valuation snapshot: P/E 20.02, EPS ₹6.44/-, P/B 8.76, RoNW 48.85%, and market cap 93.40 Cr.

To apply for Accretion Nutraveda IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.

You can check the live subscription status of Accretion Nutraveda IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.

Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.

If you pre-apply for Accretion Nutraveda IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.

You can check Accretion Nutraveda IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Accretion Nutraveda IPO allotment status on IPO Ji for quick and easy access.